MCET (MCET) Stock Price & Analysis
MCET (MCET) rose 0.00% to USD 0 as of June 10, 2026 at 02:40 UTC, according to Nexqual real-time market data.
MCET last closed at USD 0; the session ranged USD 0–0 on volume of 20,000 shares. Market capitalization is $50,009, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 02:40 UTC.
Key Statistics (as of June 10, 2026 at 02:40 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 20,000 shares |
| Market Cap | $50,009 |
| Exchange | PNK |
Technical Analysis (MCET)
Nexqual's technical model rates MCET "SELL" based on 0 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 02:40 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (MCET)
Wall Street analysts rate MCET "None", per Nexqual as of June 10, 2026 at 02:40 UTC.
| Consensus Rating | None |
|---|
Earnings (MCET)
Source: Nexqual, June 10, 2026 at 02:40 UTC.
Financials & Fundamentals (MCET)
| Total Revenue | $805,236 |
|---|---|
| Revenue Growth (YoY) | +1479.80% |
| Gross Margin | +73.06% |
| Operating Margin | -90.85% |
| Profit Margin | -31.49% |
| Current Ratio | 0.19 |
| Total Cash | $281,123 |
| Total Debt | $149,076 |
| Free Cash Flow | $-179,898 |
Source: Nexqual, June 10, 2026 at 02:40 UTC.
Financial Health Score (MCET)
Nexqual rates MCET's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:40 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $281K cash, no debt |
| Cash Flow | Weak — FCF negative: -$180K, burning cash |
| Efficiency | Mixed — No data |
Ownership (MCET)
| Insider Ownership | +9.99% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 5.00B |
| Float | 4.50B |
Source: Nexqual, June 10, 2026 at 02:40 UTC.
Leadership (MCET)
MCET is led by W. Gerald Newmin (age 88), Chairman, CEO, President, CFO, Treasurer & Secretary, per Nexqual as of June 10, 2026 at 02:40 UTC.
| Chairman, CEO, President, CFO, Treasurer & Secretary | W. Gerald Newmin (age 88) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LLBO | Lifeline BioTechnologies, Inc. | USD 0 | ▲ 40% |
| NPHC | Nutra Pharma Corp. | USD 0 | ▲ 50% |
| AFPW | ALUMIFUEL PWR CORP | USD 0 | ▲ 0% |
| LOTT | Techlott Inc. | USD 0.01 | ▲ 1.94% |
| RGBP | Regen Biopharma, Inc. | USD 0 | ▼ 33.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:40 UTC. This page is informational and not investment advice.